Literature DB >> 3010553

In vivo and in vitro models of demyelinating diseases. XV. Differentiation influences the regulation of coronavirus infection in primary explants of mouse CNS.

G A Wilson, S Beushausen, S Dales.   

Abstract

Mouse oligodendrocytes and astrocytes, in primary cerebral explant cultures, were infected with JHMV and MHV3 coronaviruses. Contrary to previous findings with neural cells from the rat (S. Beushausen and S. Dales, 1985, Virology 141, 89-101), these agents show no discrimination in the tropism and have the ability to replicate in either type of murine glial cell. Effects of the differentiation inducer dbcAMP on levels of the myelinspecific enzyme 2':3'-cyclic nucleotide-3'-phosphohydrolase (CNPase) activity and virus replication were determined. In the mouse system there was a gradual, continuous elevation of CNPase beyond 30 days whereas in comparable rat cell cultures maximum CNPase enhancement is elicited within 21 days (F. A. McMorris, 1983, J. Neurochem. 41, 506-515). After dbcAMP treatment replication of both coronaviruses was profoundly suppressed in murine oligodendrocytes, consistent with our findings on JHMV replication in treated rat oligodendrocytes. By contrast the replication of JHMV and MHV3 in dbcAMP-treated murine astrocytes was influenced only marginally. These findings provide further support for the hypothesis that susceptibility of rodents to CNS infection by coronaviruses is determined, in part, by the age-related maturation process of oligodendrocytes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3010553      PMCID: PMC7131458          DOI: 10.1016/0042-6822(86)90047-4

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  40 in total

1.  Mouse hepatitis virus-induced recurrent demyelination. A preliminary report.

Authors:  R M Herndon; D E Griffin; U McCormick; L P Weiner
Journal:  Arch Neurol       Date:  1975-01

2.  Early and late CNS-effects of corona virus infection in rats.

Authors:  K Nagashima; H Wege; V ter Meulen
Journal:  Adv Exp Med Biol       Date:  1978       Impact factor: 2.622

3.  2',3'-cyclic nucleotide 3'-phosphohydrolase in brains of mutant mice with deficient myelination.

Authors:  T Kurihara; J L Nussbaum; P Mandel
Journal:  J Neurochem       Date:  1970-07       Impact factor: 5.372

4.  Changes in the protein composition of mouse brain myelin during development.

Authors:  P Morell; S Greenfield; E Costantino-Ceccarini; H Wisniewski
Journal:  J Neurochem       Date:  1972-11       Impact factor: 5.372

5.  Immunoassays based on plastic-adsorbed gangliosides.

Authors:  J Holmgren; H Elwing; P Fredman; L Svennerholm
Journal:  Adv Exp Med Biol       Date:  1980       Impact factor: 2.622

6.  Chronic central nervous system demyelination in mice after JHM virus infection.

Authors:  S A Stohlman; L P Weiner
Journal:  Neurology       Date:  1981-01       Impact factor: 9.910

7.  Genetic study of mouse sensitivity to MHV3 infection: influence of the H-2 complex.

Authors:  E Lévy-Leblond; D Oth; J M Dupuy
Journal:  J Immunol       Date:  1979-04       Impact factor: 5.422

8.  Noncoordinate regulation of myelinogenic parameters in primary cultures of dissociated fetal rat brain.

Authors:  S E Pfeiffer; E Barbarese; S Bhat
Journal:  J Neurosci Res       Date:  1981       Impact factor: 4.164

9.  Comparison of mouse hepatitis virus strains for pathogenicity in weanling mice infected by various routes.

Authors:  N Hirano; T Murakami; F Taguchi; K Fujiwara; M Matumoto
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

10.  In vivo and in vitro models of demyelinating disease: JHM virus in the rat central nervous system localized by in situ cDNA hybridization and immunofluorescent microscopy.

Authors:  O Sorensen; S Dales
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

View more
  14 in total

1.  In vivo and in vitro models of demyelinating disease: activation of the adenylate cyclase system influences JHM virus expression in explanted rat oligodendrocytes.

Authors:  S Beushausen; S Narindrasorasak; B D Sanwal; S Dales
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

2.  Substrate regulation of ascorbate transport activity in astrocytes.

Authors:  J X Wilson; E M Jaworski; A Kulaga; S J Dixon
Journal:  Neurochem Res       Date:  1990-10       Impact factor: 3.996

3.  In vivo and in vitro models of demyelinating disease: efficiency of virus spread and formation of infectious centers among glial cells is genetically determined by the murine host.

Authors:  G A Wilson; S Dales
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

4.  Infection by coronavirus JHM of rat neurons and oligodendrocyte-type-2 astrocyte lineage cells during distinct developmental stages.

Authors:  J M Pasick; S Dales
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

5.  Spread of a neurotropic coronavirus to spinal cord white matter via neurons and astrocytes.

Authors:  N Sun; S Perlman
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

6.  Accumulation of noradrenaline and its oxidation products by cultured rodent astrocytes.

Authors:  J X Wilson; G A Wilson
Journal:  Neurochem Res       Date:  1991-11       Impact factor: 3.996

7.  Endosomal association of a protein phosphatase with high dephosphorylating activity against a coronavirus nucleocapsid protein.

Authors:  D V Mohandas; S Dales
Journal:  FEBS Lett       Date:  1991-05-06       Impact factor: 4.124

8.  Vulnerability of rat and mouse brain cells to murine hepatitis virus (JHM-strain): studies in vivo and in vitro.

Authors:  M F van Berlo; R Warringa; G Wolswijk; M Lopes-Cardozo
Journal:  Glia       Date:  1989       Impact factor: 7.452

Review 9.  The murine coronavirus as a model of trafficking and assembly of viral proteins in neural tissue.

Authors:  K Kalicharran; S Dales
Journal:  Trends Microbiol       Date:  1996-07       Impact factor: 17.079

Review 10.  Pathogenesis of virus-induced demyelination.

Authors:  J K Fazakerley; M J Buchmeier
Journal:  Adv Virus Res       Date:  1993       Impact factor: 9.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.